YENTREVE Side Effects

6962311-5 | Chest Pain, Nausea, Withdrawal Syndrome
on Aug 20, 2010 Female patient from UNITED KINGDOM , 73 years of age, weighting 121.3 lb, was diagnosed with urinary incontinence (What is urinary incontinence?) and was treated with Yentreve (View Usage). Patient experienced the following unwanted or unexpected effects: chest pain (What is chest pain?), nausea (What is nausea?), withdrawal syndrome. Yentreve dosage: 40 Mg, Daily (1/d). During the same period patient was treated with CODEINE PHOSPHATE (View Codeine Phosphate Review and Codeine Phosphate Label ), COD LIVER OIL (View Cod Liver Oil Review and Cod Liver Oil Label ), EVENING PRIMROSE OIL (View Evening Primrose Oil Review and Evening Primrose Oil Label ).

6900175-6 | Chest Pain, Nausea, Withdrawal Syndrome
Patient was taking Yentreve (View Usage). Patient had the following side effects: chest pain (What is chest pain?), nausea (What is nausea?), withdrawal syndrome on Jul 20, 2010 from UNITED KINGDOM Additional patient health information: Female patient , weighting 121.3 lb, was diagnosed with urinary incontinence (What is urinary incontinence?) and. Yentreve dosage: 40 Mg, Daily (1/d). During the same period patient was treated with CODEINE PHOSPHATE (View Codeine Phosphate Review and Codeine Phosphate Label ), COD LIVER OIL (View Cod Liver Oil Review and Cod Liver Oil Label ), EVENING PRIMROSE OIL (View Evening Primrose Oil Review and Evening Primrose Oil Label ).

6599564-1 | Cardiac Disorder
Adverse event was reported on Feb 11, 2010 by a Female patient taking Yentreve (View Usage) (Dosage: ) . Location: IRELAND , 42 years of age, After Yentreve was administered, patient had the following side effects: cardiac disorder. Patient was hospitalized.

6469773-0 | Bradycardia, Supraventricular Extrasystoles, Tachycardia
on May 19, 2008 Male patient from GERMANY , 81 years of age, was diagnosed with stress urinary incontinence and was treated with Yentreve (View Usage). Patient experienced the following unwanted or unexpected effects: bradycardia, supraventricular extrasystoles, tachycardia. Yentreve dosage: One Tablet, Daily (1/d). During the same period patient was treated with DELIX (2.5 Mg, Daily (1/d)) (View Delix Review and Delix Label ), VIANI (1 D/f, Each Morning) (View Viani Review and Viani Label ), SPIRIVA (1 D/f, Each Morning) (View Spiriva Review and Spiriva Label ).


6468893-4 | Asphyxia, Cardiac Failure Acute, Cardiac Hypertrophy, Pleural Haemorrhage, Pulmonary Oedema
on Jan 18, 2008 Female patient from UNITED KINGDOM , 51 years of age, weighting 252.4 lb, was diagnosed with urinary incontinence (What is urinary incontinence?) and was treated with Yentreve (View Usage). Patient had the following side effects: asphyxia, cardiac failure acute, cardiac hypertrophy, pleural haemorrhage, pulmonary oedema. Yentreve dosage: 20 Mg, 2/d. During the same period patient was treated with BENDROFLUAZIDE (View Bendrofluazide Review and Bendrofluazide Label ), CO CODAMOL (View Co-codamol Review and Co-codamol Label ), GLICLAZIDE (View Gliclazide Review and Gliclazide Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), ALBUTEROL (1 D/f, As Needed) (View Albuterol Review and Albuterol Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ).

6386931-4 | Circulatory Collapse
Patient was taking Yentreve (View Usage). After Yentreve was administered, patient had the following side effects: circulatory collapse on Sep 23, 2009 from GERMANY Additional patient health information: Female patient , weighting 132.3 lb, was diagnosed with urinary incontinence (What is urinary incontinence?), cardiac failure and. Yentreve dosage: Unk, Daily (1/d). During the same period patient was treated with CAPTOPRIL (View Captopril Review and Captopril Label ), ONE ALPHA (View One-alpha Review and One-alpha Label ), CITALOPRAM HYDROBROMIDE (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), LANITOP (View Lanitop Review and Lanitop Label ).

6359758-7 | Accidental Exposure, Accidental Overdose
Adverse event was reported on Sep 07, 2009 by a Male patient taking Yentreve (View Usage) (Dosage: 40 Mg X 1 Tablet) . Location: GERMANY , weighting 37.48 lb, Patient experienced the following unwanted or unexpected effects: accidental exposure, accidental overdose. During the same period patient was treated with ASPIRIN (100 Mg X 1) (View Aspirin Review and Aspirin Label ), L THYROXIN (1 Tablet, Unk) (View L-thyroxin Review and L-thyroxin Label ), NEBILET (5 Mg X 2) (View Nebilet Review and Nebilet Label ). Patient was hospitalized.

6218877-6 | Road Traffic Accident, Visual Field Defect
on May 25, 2009 Female patient from SWEDEN , 45 years of age, was treated with Yentreve (View Usage). Patient had the following side effects: road traffic accident, visual field defect. Yentreve dosage: 40 Mg, 2/d.

5963996-2 | Anxiety, Hypertensive Crisis, Nightmare, Stupor
on Nov 11, 2008 Female patient from GERMANY , weighting 132.3 lb, was diagnosed with stress urinary incontinence and was treated with Yentreve (View Usage). After Yentreve was administered, patient had the following side effects: anxiety (What is anxiety?), hypertensive crisis, nightmare, stupor. Yentreve dosage: 20 Mg, 2/d. During the same period patient was treated with ESTRADERM (View Estraderm Review and Estraderm Label ). Patient was hospitalized.

5945271-5 | Abdominal Pain Lower, Body Temperature Increased, Disorientation, Disturbance In Attention, Dry Mouth, Dysgeusia, Fatigue, Feeling Abnormal, Gastroenteritis
Patient was taking Yentreve (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain lower, body temperature increased, disorientation, disturbance in attention, dry mouth, dysgeusia, fatigue, feeling abnormal, gastroenteritis (What is gastroenteritis?) on Oct 27, 2008 from UNITED KINGDOM Additional patient health information: Female patient , weighting 146.4 lb, was diagnosed with stress urinary incontinence, palpitations and. Yentreve dosage: 40 Mg, 2/d. During the same period patient was treated with BISOPROLOL FUMARATE (5 Mg, Daily (1/d)) (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), TRIMETHOPRIM (View Trimethoprim Review and Trimethoprim Label ).

5924524-0 | Ventricular Tachycardia
Adverse event was reported on Oct 13, 2008 by a Male patient taking Yentreve (View Usage) (Dosage: 40 Mg, Daily (1/d)) was diagnosed with incontinence and. Location: GERMANY , 76 years of age, Patient had the following side effects: ventricular tachycardia. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ).

5858605-7 | Abdominal Pain Lower, Body Temperature Increased, Disorientation, Disturbance In Attention, Dry Mouth, Dysgeusia, Fatigue, Feeling Abnormal, Headache
on Aug 13, 2008 Female patient from UNITED KINGDOM , weighting 146.4 lb, was diagnosed with stress urinary incontinence, palpitations and was treated with Yentreve (View Usage). After Yentreve was administered, patient had the following side effects: abdominal pain lower, body temperature increased, disorientation, disturbance in attention, dry mouth, dysgeusia, fatigue, feeling abnormal, headache (What is headache?). Yentreve dosage: 40 Mg, 2/d. During the same period patient was treated with BISOPROLOL FUMARATE (5 Mg, Daily (1/d)) (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ).

5834559-4 | Dizziness, Dysarthria, Fatigue, Feeling Drunk, Gait Disturbance, Headache, Hypertension, Loss Of Libido
on Jul 24, 2008 Female patient from UNITED KINGDOM , weighting 168.0 lb, was diagnosed with stress urinary incontinence and was treated with Yentreve (View Usage). Patient experienced the following unwanted or unexpected effects: dizziness (What is dizziness?), dysarthria, fatigue, feeling drunk, gait disturbance, headache (What is headache?), hypertension, loss of libido. Yentreve dosage: 40 - 20 Mg (initially Less Than 20 Mg).

5826145-7 | Cold Sweat, Dry Mouth, Headache, Oropharyngeal Pain, Social Avoidant Behaviour, Weight Decreased
Patient was taking Yentreve (View Usage). Patient had the following side effects: cold sweat, dry mouth, headache (What is headache?), oropharyngeal pain, social avoidant behaviour, weight decreased on Jul 17, 2008 from UNITED KINGDOM Additional patient health information: Female patient , 56 years of age, weighting 167.6 lb, was diagnosed with stress urinary incontinence, menopause (What is menopause?), gastrooesophageal reflux disease and. Yentreve dosage: . During the same period patient was treated with FEMOSTON (View Femoston Review and Femoston Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ).

5788013-9 | Narcolepsy, Nausea
Adverse event was reported on Jun 13, 2008 by a Female patient taking Yentreve (View Usage) (Dosage: 40 Mg, 2/d) was diagnosed with stress urinary incontinence and. Location: UNITED KINGDOM , 46 years of age, After Yentreve was administered, patient had the following side effects: narcolepsy, nausea (What is nausea?).

5751117-0 | Bradycardia, Supraventricular Extrasystoles, Tachycardia
on May 19, 2008 Male patient from GERMANY , 81 years of age, was diagnosed with stress urinary incontinence and was treated with Yentreve (View Usage). Patient experienced the following unwanted or unexpected effects: bradycardia, supraventricular extrasystoles, tachycardia. Yentreve dosage: One Tablet, Daily (1/d). During the same period patient was treated with DELIX (2.5 Mg, Daily (1/d)) (View Delix Review and Delix Label ), VIANI (1 D/f, Each Morning) (View Viani Review and Viani Label ), SPIRIVA (1 D/f, Each Morning) (View Spiriva Review and Spiriva Label ).

5643402-8 | Atrial Fibrillation
on Feb 19, 2008 Female patient from GERMANY , 70 years of age, was diagnosed with stress urinary incontinence and was treated with Yentreve (View Usage). Patient had the following side effects: atrial fibrillation (What is atrial fibrillation?). Yentreve dosage: 40 Mg, 2/d. Patient was hospitalized.

5618903-9 | Fatigue, Narcolepsy, Nausea
Patient was taking Yentreve (View Usage). After Yentreve was administered, patient had the following side effects: fatigue, narcolepsy, nausea (What is nausea?) on Jan 24, 2008 from UNITED KINGDOM Additional patient health information: Female patient , 46 years of age, was diagnosed with stress urinary incontinence and. Yentreve dosage: 40 Mg, 2/d.

5609854-4 | Asphyxia, Cardiac Failure Acute, Cardiac Hypertrophy, Pleural Haemorrhage, Pulmonary Oedema
Adverse event was reported on Jan 18, 2008 by a Female patient taking Yentreve (View Usage) (Dosage: 20 Mg, 2/d) was diagnosed with urinary incontinence (What is urinary incontinence?) and. Location: UNITED KINGDOM , 51 years of age, weighting 252.4 lb, Patient experienced the following unwanted or unexpected effects: asphyxia, cardiac failure acute, cardiac hypertrophy, pleural haemorrhage, pulmonary oedema. During the same period patient was treated with BENDROFLUAZIDE (View Bendrofluazide Review and Bendrofluazide Label ), CO CODAMOL (View Co-codamol Review and Co-codamol Label ), GLICLAZIDE (View Gliclazide Review and Gliclazide Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), ALBUTEROL (1 D/f, As Needed) (View Albuterol Review and Albuterol Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ).

5598709-X | Angina Pectoris, Myocardial Ischaemia
on Jan 10, 2008 Male patient from UNITED KINGDOM , 72 years of age, weighting 165.3 lb, was diagnosed with urinary incontinence (What is urinary incontinence?) and was treated with Yentreve (View Usage). Patient had the following side effects: angina pectoris, myocardial ischaemia. Yentreve dosage: . During the same period patient was treated with ASPIRIN (75 Mg, Daily (1/d)) (View Aspirin Review and Aspirin Label ), ATORVASTATIN (View Atorvastatin Review and Atorvastatin Label ), BENDROFLUMETHIAZIDE (2.5 Mg, Daily (1/d)) (View Bendroflumethiazide Review and Bendroflumethiazide Label ), DOCUSATE SODIUM (200 Mg, 2/d) (View Docusate Sodium Review and Docusate Sodium Label ), FINASTERIDE (5 Mg, Daily (1/d)) (View Finasteride Review and Finasteride Label ), ISPAGHULA HUSK (1 D/f, 2/d) (View Ispaghula Husk Review and Ispaghula Husk Label ), PROPRANOLOL HYDROCHLORIDE (80 Mg, Daily (1/d)) (View Propranolol Hydrochloride Review and Propranolol Hydrochloride Label ), SENNA (View Senna Review and Senna Label ).

5579533-0 | Angina Pectoris, Myocardial Ischaemia
on Dec 20, 2007 Male patient from UNITED KINGDOM , 72 years of age, weighting 165.3 lb, was diagnosed with urinary incontinence (What is urinary incontinence?) and was treated with Yentreve (View Usage). After Yentreve was administered, patient had the following side effects: angina pectoris, myocardial ischaemia. Yentreve dosage: . During the same period patient was treated with ASPIRIN (75 Mg, Daily (1/d)) (View Aspirin Review and Aspirin Label ), ATORVASTATIN (View Atorvastatin Review and Atorvastatin Label ), BENDROFLUMETHIAZIDE (2.5 Mg, Daily (1/d)) (View Bendroflumethiazide Review and Bendroflumethiazide Label ), DOCUSATE SODIUM (200 Mg, 2/d) (View Docusate Sodium Review and Docusate Sodium Label ), FINASTERIDE (5 Mg, Daily (1/d)) (View Finasteride Review and Finasteride Label ), ISPAGHULA HUSK (1 D/f, 2/d) (View Ispaghula Husk Review and Ispaghula Husk Label ), PROPRANOLOL (80 Mg, Daily (1/d)) (View Propranolol Review and Propranolol Label ), SENNA (View Senna Review and Senna Label ).

5569563-7 | Hyperhidrosis, Panic Reaction
Patient was taking Yentreve (View Usage). Patient experienced the following unwanted or unexpected effects: hyperhidrosis, panic reaction on Dec 12, 2007 from UNITED KINGDOM Additional patient health information: Female patient , 63 years of age, weighting 175.4 lb, was diagnosed with urinary tract disorder, pain (What is pain?), laryngitis and. Yentreve dosage: . During the same period patient was treated with CO CODAMOL (View Co-codamol Review and Co-codamol Label ), ERYTHROMYCIN (View Erythromycin Review and Erythromycin Label ), MELOXICAM (View Meloxicam Review and Meloxicam Label ).

5530777-3 | Bradycardia, Supraventricular Extrasystoles, Tachycardia
Adverse event was reported on Nov 20, 2007 by a Male patient taking Yentreve (View Usage) (Dosage: One Tablet, Daily (1/d)) was diagnosed with stress urinary incontinence and. Location: GERMANY , 81 years of age, Patient had the following side effects: bradycardia, supraventricular extrasystoles, tachycardia. During the same period patient was treated with RAMIPRIL (2.5 Mg, Daily (1/d)) (View Ramipril Review and Ramipril Label ), VIANI (1 D/f, Each Morning) (View Viani Review and Viani Label ), SPIRIVA (1 D/f, Each Morning) (View Spiriva Review and Spiriva Label ).

5447838-X | Dizziness, Fall, Feeling Drunk, Gait Disturbance
on Aug 30, 2007 Female patient from UNITED KINGDOM , 83 years of age, weighting 127.9 lb, was diagnosed with hypertonic bladder, osteopenia, diabetes mellitus, gastrooesophageal reflux disease, pain (What is pain?), hypercholesterolaemia, breast cancer (What is breast cancer?), osteoarthritis (What is osteoarthritis?) and was treated with Yentreve (View Usage). After Yentreve was administered, patient had the following side effects: dizziness (What is dizziness?), fall (What is fall?), feeling drunk, gait disturbance. Yentreve dosage: . During the same period patient was treated with CALCICHEW (View Calcichew Review and Calcichew Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), PARACETAMOL (Unk, As Needed) (View Paracetamol Review and Paracetamol Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), TAMOXIFEN CITRATE (View Tamoxifen Citrate Review and Tamoxifen Citrate Label ), TRAMADOL HCL (View Tramadol Hcl Review and Tramadol Hcl Label ).

5447827-5 | Blood Pressure Systolic Decreased
on Aug 29, 2007 Female patient from UNITED KINGDOM , 72 years of age, was diagnosed with stress urinary incontinence, hypertension and was treated with Yentreve (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure systolic decreased. Yentreve dosage: 20 Mg, 2/d. During the same period patient was treated with BENDROFLUMETHIAZIDE (View Bendroflumethiazide Review and Bendroflumethiazide Label ), MOXONIDINE (200 Mg, 2/d) (View Moxonidine Review and Moxonidine Label ).

5368807-4 | Elevated Mood, Energy Increased, Poor Quality Sleep
Patient was taking Yentreve (View Usage). Patient had the following side effects: elevated mood, energy increased, poor quality sleep on Jun 14, 2007 from UNITED KINGDOM Additional patient health information: Female patient , 50 years of age, weighting 138.9 lb, was diagnosed with stress urinary incontinence and. Yentreve dosage: 40 Mg, 2/d. During the same period patient was treated with EVOREL SEQUI (View Evorel Sequi Review and Evorel Sequi Label ).

5367865-0 | Elevated Mood, Energy Increased, Poor Quality Sleep
Adverse event was reported on Jun 14, 2007 by a Female patient taking Yentreve (View Usage) (Dosage: 40 Mg, 2/d) was diagnosed with stress urinary incontinence and. Location: UNITED KINGDOM , 50 years of age, weighting 138.9 lb, After Yentreve was administered, patient had the following side effects: elevated mood, energy increased, poor quality sleep. During the same period patient was treated with EVOREL SEQUI (View Evorel Sequi Review and Evorel Sequi Label ).

5325589-X | Psychotic Disorder
on May 02, 2007 Female patient from MEXICO , 36 years of age, was diagnosed with urinary incontinence (What is urinary incontinence?) and was treated with Yentreve (View Usage). Patient experienced the following unwanted or unexpected effects: psychotic disorder (What is psychotic disorder?). Yentreve dosage: . Patient was hospitalized.

5316120-3 | Dizziness, Paraesthesia
on Apr 23, 2007 Female patient from UNITED KINGDOM , 42 years of age, weighting 140.0 lb, was diagnosed with stress urinary incontinence, pain (What is pain?) and was treated with Yentreve (View Usage). Patient had the following side effects: dizziness (What is dizziness?), paraesthesia. Yentreve dosage: 40 Mg, 2/d. During the same period patient was treated with BECLOMETHASONE DIPROPIONATE (2 D/f, 4/d) (View Beclomethasone Dipropionate Review and Beclomethasone Dipropionate Label ), CO CODAMOL (2 Mg, 4/d) (View Co-codamol Review and Co-codamol Label ), OMEPRAZOLE (20 Mg, Daily (1/d)) (View Omeprazole Review and Omeprazole Label ), SALBUTAMOL (2 D/f, As Needed) (View Salbutamol Review and Salbutamol Label ), SALMETEROL (2 D/f, 4/d) (View Salmeterol Review and Salmeterol Label ), TEMAZEPAM (10 Mg, As Needed) (View Temazepam Review and Temazepam Label ).

5304805-4 | Fall, Nausea, Paraesthesia
Patient was taking Yentreve (View Usage). After Yentreve was administered, patient had the following side effects: fall (What is fall?), nausea (What is nausea?), paraesthesia on Apr 11, 2007 from UNITED KINGDOM Additional patient health information: Female patient , 42 years of age, weighting 140.0 lb, was diagnosed with stress urinary incontinence, pain (What is pain?) and. Yentreve dosage: 40 Mg, 2/d. During the same period patient was treated with BECLOMETHASONE DIPROPIONATE (2 D/f, 4/d) (View Beclomethasone Dipropionate Review and Beclomethasone Dipropionate Label ), CO CODAMOL (2 Mg, 4/d) (View Co-codamol Review and Co-codamol Label ), OMEPRAZOLE (20 Mg, Daily (1/d)) (View Omeprazole Review and Omeprazole Label ), SALBUTAMOL (2 D/f, As Needed) (View Salbutamol Review and Salbutamol Label ), SALMETEROL (2 D/f, 4/d) (View Salmeterol Review and Salmeterol Label ), TEMAZEPAM (10 Mg, As Needed) (View Temazepam Review and Temazepam Label ).

5283114-6 | Anxiety, Blood Creatine Phosphokinase Increased, Chest Pain, Extrapyramidal Disorder, Hyponatraemia, Tremor
Adverse event was reported on Mar 22, 2007 by a Female patient taking Yentreve (View Usage) (Dosage: 20 Mg, Daily (1/d)) was diagnosed with stress urinary incontinence and. Location: GERMANY , 77 years of age, Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), blood creatine phosphokinase increased, chest pain (What is chest pain?), extrapyramidal disorder, hyponatraemia, tremor. During the same period patient was treated with BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), TRIAMTERENE AND HYDROCHLOROTHIAZIDE (Unk, Unk) (View Triamterene And Hydrochlorothiazide Review and Triamterene And Hydrochlorothiazide Label ), ESOMEPRAZOLE MAGNESIUM (View Esomeprazole Magnesium Review and Esomeprazole Magnesium Label ), ASPIRIN (100 Mg, Unk) (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

5263265-2 | Aspartate Aminotransferase Increased, Glutamate Dehydrogenase Increased
on Feb 26, 2007 Female patient from GERMANY , 55 years of age, was diagnosed with stress urinary incontinence and was treated with Yentreve (View Usage). Patient had the following side effects: aspartate aminotransferase increased, glutamate dehydrogenase increased. Yentreve dosage: 20 Mg, 2/d. During the same period patient was treated with METOPROLOL SUCCINATE (View Metoprolol Succinate Review and Metoprolol Succinate Label ).

5253472-7 | Psychotic Disorder, Suicidal Ideation
on Feb 16, 2007 Male patient from GERMANY , 69 years of age, was diagnosed with stress urinary incontinence and was treated with Yentreve (View Usage). After Yentreve was administered, patient had the following side effects: psychotic disorder (What is psychotic disorder?), suicidal ideation. Yentreve dosage: 40 Mg, 2/d. Patient was hospitalized.

5240776-7 | Psychotic Disorder, Suicidal Ideation
Patient was taking Yentreve (View Usage). Patient experienced the following unwanted or unexpected effects: psychotic disorder (What is psychotic disorder?), suicidal ideation on Feb 06, 2007 from GERMANY Additional patient health information: Male patient , 69 years of age, was diagnosed with stress urinary incontinence and. Yentreve dosage: 40 Mg, 2/d. Patient was hospitalized.

5237674-1 | Dizziness, Fall
Adverse event was reported on Feb 01, 2007 by a Female patient taking Yentreve (View Usage) (Dosage: 20 Mg, 2/d) was diagnosed with urinary incontinence (What is urinary incontinence?) and. Location: GERMANY , 84 years of age, Patient had the following side effects: dizziness (What is dizziness?), fall (What is fall?). During the same period patient was treated with TAMOXIFEN CITRATE (20 Mg, Unk) (View Tamoxifen Citrate Review and Tamoxifen Citrate Label ).

5234534-7 | Fascial Operation
on Jan 29, 2007 Female patient from GERMANY , 67 years of age, weighting 156.5 lb, was diagnosed with stress urinary incontinence and was treated with Yentreve (View Usage). After Yentreve was administered, patient had the following side effects: fascial operation. Yentreve dosage: 60 Mg, Daily (1/d). Patient was hospitalized.

5228982-9 | Multi-organ Failure, Non-hodgkin's Lymphoma
on Jan 22, 2007 Female patient from GERMANY , 73 years of age, was diagnosed with stress urinary incontinence, hypertension and was treated with Yentreve (View Usage). Patient experienced the following unwanted or unexpected effects: multi-organ failure, non-hodgkin's lymphoma. Yentreve dosage: 20 Mg, 2/d. During the same period patient was treated with ENAHEXAL (Unk, 2/d) (View Enahexal Review and Enahexal Label ), LOFTAN (4 Mg, Daily (1/d)) (View Loftan Review and Loftan Label ), THEOPHYLLINE (300 Mg, Daily (1/d)) (View Theophylline Review and Theophylline Label ), DICLAC (Unk, As Needed) (View Diclac Review and Diclac Label ).

5227125-5 | Blood Lactate Dehydrogenase Increased, Dizziness, Gamma-glutamyltransferase Abnormal, Hyperhidrosis, Skin Odour Abnormal, Urinary Incontinence, Urine Output Decreased
Patient was taking Yentreve (View Usage). Patient had the following side effects: blood lactate dehydrogenase increased, dizziness (What is dizziness?), gamma-glutamyltransferase abnormal, hyperhidrosis, skin odour abnormal, urinary incontinence (What is urinary incontinence?), urine output decreased on Jan 18, 2007 from GERMANY Additional patient health information: Female patient , 70 years of age, was diagnosed with micturition urgency, nasopharyngitis and. Yentreve dosage: 20 Mg, Unk. During the same period patient was treated with ELOBACT (View Elobact Review and Elobact Label ).

5226712-8 | Dizziness, Fall
Adverse event was reported on Jan 19, 2007 by a Female patient taking Yentreve (View Usage) (Dosage: 20 Mg, 2/d) was diagnosed with urinary incontinence (What is urinary incontinence?) and. Location: GERMANY , 84 years of age, After Yentreve was administered, patient had the following side effects: dizziness (What is dizziness?), fall (What is fall?). During the same period patient was treated with TAMOXIFEN CITRATE (20 Mg, Unk) (View Tamoxifen Citrate Review and Tamoxifen Citrate Label ).

5219508-4 | Blood Pressure Increased, Burning Sensation, Cardiac Disorder, Feeling Hot, Headache, Pain, Tremor
on Jan 15, 2007 Female patient from GERMANY , 72 years of age, was treated with Yentreve (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure increased, burning sensation, cardiac disorder, feeling hot, headache (What is headache?), pain (What is pain?), tremor. Yentreve dosage: 20 Mg, Daily (1/d). During the same period patient was treated with CONCOR (5 Mg, Unk) (View Concor Review and Concor Label ), PENTAERYTHRITOL TETRANITRATE (80 Mg, Unk) (View Pentaerythritol Tetranitrate Review and Pentaerythritol Tetranitrate Label ).

5214235-1 | Blood Lactate Dehydrogenase Increased, Gamma-glutamyltransferase Abnormal, Hyperhidrosis, Skin Odour Abnormal, Urine Output Decreased
on Nov 21, 2006 Female patient from GERMANY , 70 years of age, was diagnosed with urinary incontinence (What is urinary incontinence?), nasopharyngitis and was treated with Yentreve (View Usage). Patient had the following side effects: blood lactate dehydrogenase increased, gamma-glutamyltransferase abnormal, hyperhidrosis, skin odour abnormal, urine output decreased. Yentreve dosage: 20 Mg, Unk. During the same period patient was treated with ELOBACT (View Elobact Review and Elobact Label ).

5208383-X | Cardiac Failure
Patient was taking Yentreve (View Usage). After Yentreve was administered, patient had the following side effects: cardiac failure on Jan 03, 2007 from GERMANY Additional patient health information: Female patient , 78 years of age, was diagnosed with urinary incontinence (What is urinary incontinence?) and. Yentreve dosage: Unk, Unk.

5190432-9 | Fall, Hip Surgery
Adverse event was reported on Dec 14, 2006 by a Female patient taking Yentreve (View Usage) (Dosage: 20 Mg, Daily (1/d)) was diagnosed with stress urinary incontinence, vaginal infection and. Location: GERMANY , 78 years of age, weighting 176.4 lb, Patient experienced the following unwanted or unexpected effects: fall (What is fall?), hip surgery. During the same period patient was treated with ESTROGENS (0.5 Mg, Unk) (View Estrogens Review and Estrogens Label ). Patient was hospitalized.

5177231-9 |
on Dec 05, 2006 Female patient from GERMANY , 78 years of age, was diagnosed with urinary incontinence (What is urinary incontinence?) and was treated with Yentreve (View Usage). . Yentreve dosage: Unk, Unk.

5177226-5 | Cardiac Failure Acute, Cardiac Hypertrophy
on Dec 06, 2006 Female patient from UNITED KINGDOM , 51 years of age, weighting 252.4 lb, was diagnosed with urinary incontinence (What is urinary incontinence?) and was treated with Yentreve (View Usage). After Yentreve was administered, patient had the following side effects: cardiac failure acute, cardiac hypertrophy. Yentreve dosage: 20 Mg, 2/d. During the same period patient was treated with BENDROFLUAZIDE (View Bendrofluazide Review and Bendrofluazide Label ), ACETAMINOPHEN W/ CODEINE (View Acetaminophen W/ Codeine Review and Acetaminophen W/ Codeine Label ), GLICLAZIDE (View Gliclazide Review and Gliclazide Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), METFORMIN (View Metformin Review and Metformin Label ), VENTOLIN (1 D/f, As Needed) (View Ventolin Review and Ventolin Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ).

5166986-5 | Premature Baby, Small For Dates Baby
Patient was taking Yentreve (View Usage). Patient experienced the following unwanted or unexpected effects: premature baby, small for dates baby on Nov 07, 2006 from SWEDEN Additional patient health information: Female patient , weighting 2.68 lb, . Yentreve dosage: . During the same period patient was treated with HEPARIN (View Heparin Review and Heparin Label ).

5164921-7 | Cardiovascular Disorder, Circulatory Collapse
Adverse event was reported on Nov 20, 2006 by a Female patient taking Yentreve (View Usage) (Dosage: 20 Mg, Daily (1/d)) was diagnosed with stress urinary incontinence and. Location: GERMANY , 29 years of age, Patient had the following side effects: cardiovascular disorder, circulatory collapse.

5162984-6 | Depressed Mood, Panic Attack, Social Avoidant Behaviour
on Nov 20, 2006 Female patient from UNITED KINGDOM , 44 years of age, was diagnosed with urinary incontinence (What is urinary incontinence?) and was treated with Yentreve (View Usage). After Yentreve was administered, patient had the following side effects: depressed mood, panic attack, social avoidant behaviour. Yentreve dosage: 40 Mg, 2/d. During the same period patient was treated with ANTIHISTAMINES (View Antihistamines Review and Antihistamines Label ).

5162982-2 | Cardiovascular Disorder, Circulatory Collapse
on Nov 20, 2006 Female patient from GERMANY , 29 years of age, was diagnosed with stress urinary incontinence and was treated with Yentreve (View Usage). Patient experienced the following unwanted or unexpected effects: cardiovascular disorder, circulatory collapse. Yentreve dosage: 20 Mg, Daily (1/d).

5154263-8 | Amnesia, Confusional State, Coordination Abnormal, Decreased Appetite, Feeling Abnormal, Staring, Weight Decreased
Patient was taking Yentreve (View Usage). Patient had the following side effects: amnesia, confusional state, coordination abnormal, decreased appetite, feeling abnormal, staring, weight decreased on Nov 07, 2006 from UNITED KINGDOM Additional patient health information: Female patient , 78 years of age, weighting 187.4 lb, was diagnosed with stress urinary incontinence and. Yentreve dosage: 20 Mg, 2/d. During the same period patient was treated with ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), METFORMIN (View Metformin Review and Metformin Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), SALMETEROL (View Salmeterol Review and Salmeterol Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), TOLTERODINE (View Tolterodine Review and Tolterodine Label ).